A study to investigate vepoloxamer (Carmeseal-MD) for Duchenne muscular dystrophy
Latest Information Update: 24 Sep 2016
At a glance
- Drugs Poloxamer 188 (Primary)
- Indications Duchenne muscular dystrophy
- Focus Adverse reactions
Most Recent Events
- 07 Sep 2016 According to a Phrixus Pharmaceuticals media release, the US FDA allowed IND application for poloxamer-188 in DMD.
- 19 Jun 2015 New trial record